Jane Boswick

A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction.

Eric J. Topol, Barry S. George, Dean J. Kereiakes et al. · Circulation · 1989 · 275 citations

Bleeding Complications, Coronary Artery Disease, Acute Myocardial Infarction +16

Use of initial ST-segment deviation for prediction of final electrocardiographic size of acute myocardial infarcts

Harry R. Aldrich, Nancy B. Wagner, Jane Boswick et al. · The American Journal of Cardiology · 1988 · 217 citations

Electrophysiological Evaluation, Cardiovascular Disease, Initial St-segment Deviation +13

Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction

Robert M. Califf, Eric J. Topol, Barry S. George et al. · The American Journal of Medicine · 1988 · 160 citations

Thrombosis, Cardiovascular Disease, Medicine +9

Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) I trial.

Robert M. Califf, Eric J. Topol, Barry S. George et al. · Circulation · 1988 · 143 citations

Percutaneous Coronary Intervention, Thrombosis, Residual Stenosis +12

Prognostic implications and predictors of enhanced regional wall motion of the noninfarct zone after thrombolysis and angioplasty therapy of acute myocardial infarction. The TAMI Study Groups.

Cindy L. Grines, Eric J. Topol, Robert M. Califf et al. · Circulation · 1989 · 103 citations · Full text

Heart Failure, Noninfarct Zone, Coronary Artery Disease +16